ABVX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Abivax SA American Depositary Shares · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 124.9 USD
-0.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 5.2% above the Trend Line and sits at 70.7% of its 52-week range. The latest completed week returned -0.6%, after a -13.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 49/100 conviction, while the latest news-sentiment score is 62/100. Near-term considerations: volume confirmation is below normal; earnings are due in 44d.

Setup score 41 out of 100
Latest Close 124.9 USD 31 Jul 2026
1W Return -0.6% latest completed week
4W Return -13.6% short-term follow-through
12W Return 1.8% quarterly tape
Trend Breadth 84.6% 44 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 2-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 7 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.6% Latest completed week; four-week move -13.6%. Indicator stack 53/67 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.37% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 49/100 conviction; expected move 7.5%. News sentiment 62/100 51 relevant articles in the latest sentiment read. Event risk 44d Next report is scheduled for 14 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.2% above the Trend Line and sits at 70.7% of its 52-week range. The latest completed week returned -0.6%, after a -13.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5312-week average 0.44

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers77 reversal markers

No recent accumulation markers. 7 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.6% over four weeks, 1.8% over 12 weeks, and 73.6% over one year. The current trend has remained active for 2 consecutive weeks.

Performance by holding period

1W-0.6%
4W-13.6%
12W1.8%
26W12.4%
52W73.6%
Active trend streak2 weeks
Active weeks in one year44
Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.33Latest activity-pressure read.
Pressure change134.4%Four-week change in activity pressure.
Leadership3.70Latest relative-leadership reading.
RS change-83.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength75/100Blend of value, momentum, and quality. Underlying universe rank 26; rank 1 is best.
Value62/100Relative valuation strength. Underlying universe rank 39; rank 1 is best.
Quality61/100Profitability and accounting quality. Underlying universe rank 40; rank 1 is best.
Momentum62/100Medium-term price momentum. Underlying universe rank 39; rank 1 is best.
Growth62/100Revenue and earnings growth. Underlying universe rank 39; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-2.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-5.9%
Net share repurchases relative to market value.
Shareholder yield
-5.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ABVX shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.37, expected move of 7.5%, and Sharemaestro trend signal active.

Conviction49/100
Expected move7.5%
Put/call volume0.37
Pressure52
Speculation41
Volatility77
Trend agreement40
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment62/100

Weighted news tone is positive across 51 relevant articles.

28 positive · 18 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings44dNext report is scheduled for 14 Sep 2026; event risk rises as the date approaches.
Options expected move7.5%Nearest-chain priced movement where available.
52-week drawdown-16.1%Distance below the 52-week high.
13-week volatility15.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+48.4%Week of 3 Jul.
Worst week-23.4%Week of 5 Jun.
Latest week-0.6%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains2
Flat weeks0
Modest losses4
Sharp losses9
Recent vol15.6%13-week weekly-return volatility.
Base vol10.5%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew8.0% / -6.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis36/100

Latest 12-week confirmation: trend 4/12, activity pressure 3/12, relative leadership 8/12.

Activity pressure 0.53; 7 reversal markers Next-Week ExpectancyPositive 56.37%

Next-week expectancy is positive with a 56.37% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors65/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 83; Small Cap Core rank 46 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options46/100

ABVX shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.37, expected move of 7.5%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 7.5% Sentiment62/100

Weighted news tone is positive across 51 relevant articles.

Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC Insiders50/100

No recent insider transaction evidence is stored.

 Earnings44d

Next report is scheduled for 14 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026124.9 USD-0.6%118.7 USD46.79 USD0.333.705.6MOn
24 Jul 2026125.7 USD-8.0%119.0 USD46.25 USD0.455.514.2MOn
17 Jul 2026136.7 USD-2.3%119.6 USD45.70 USD0.0313.705.9MOff
10 Jul 2026139.9 USD-3.3%118.9 USD45.06 USD-0.4613.835.9MOff
3 Jul 2026144.7 USD48.4%118.4 USD44.40 USD-0.9622.2920.5MOff
26 Jun 202697.50 USD-1.7%117.4 USD43.69 USD-1.31-15.0014.0MOff
19 Jun 202699.15 USD2.7%118.3 USD43.30 USD-0.86-16.227.5MOff
12 Jun 202696.55 USD-4.9%119.0 USD42.90 USD-0.58-14.986.7MOff
5 Jun 2026101.5 USD-23.4%119.4 USD42.51 USD-0.55-7.1739.3MOff
29 May 2026132.6 USD8.7%119.5 USD42.08 USD-0.5217.685.4MOn
22 May 2026122.0 USD6.5%118.5 USD41.41 USD-0.9013.786.0MOff
15 May 2026114.5 USD-6.7%117.5 USD40.82 USD-1.1510.383.8MOn
8 May 2026122.7 USD4.4%116.8 USD40.27 USD-1.0020.285.3MOn
1 May 2026117.6 USD2.7%115.8 USD39.65 USD-1.0924.243.9MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.